These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Triptans to the rescue: effective therapy for migraine headaches in the workplace. Bartleson JD Mayo Clin Proc; 2000 Aug; 75(8):780-1. PubMed ID: 10943229 [No Abstract] [Full Text] [Related]
10. Building on the sumatriptan experience: the development of naratriptan. Connor HE Cephalalgia; 2001; 21 Suppl 1():32-4. PubMed ID: 11678820 [No Abstract] [Full Text] [Related]
16. Establishing a standard of speed for assessing the efficacy of the serotonin(1B/1D) agonists (triptans). Marcus DA Arch Neurol; 2001 Jul; 58(7):1056-8. PubMed ID: 11448293 [TBL] [Abstract][Full Text] [Related]
17. Sumatriptan versus eletriptan: which is best? Dodick DW Lancet Neurol; 2002 Dec; 1(8):474. PubMed ID: 12849329 [No Abstract] [Full Text] [Related]
18. Naratriptan for the treatment of acute migraine: meta-analysis of randomised controlled trials. Ashcroft DM; Millson D Pharmacoepidemiol Drug Saf; 2004 Feb; 13(2):73-82. PubMed ID: 14998068 [TBL] [Abstract][Full Text] [Related]
19. What matters is not the differences between triptans, but the differences between patients. Saper JR Arch Neurol; 2001 Sep; 58(9):1481-2. PubMed ID: 11559323 [No Abstract] [Full Text] [Related]
20. Vasoconstrictive properties of the 5HT1B/1D agonists: response to Dahlöf and Mathew. Goldstein D Cephalalgia; 1999 Jun; 19(5):536-7. PubMed ID: 10403072 [No Abstract] [Full Text] [Related] [Next] [New Search]